BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 7843932)

  • 41. Medication use, medical conditions, and the risk of human papillomavirus infection and subsequent cervical intraepithelial neoplasia 3 among women with mild cytologic abnormalities.
    Wang SS; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):542-5. PubMed ID: 15734987
    [No Abstract]   [Full Text] [Related]  

  • 42. [The role of tumor-related papillomavirus infection of the genitals in the genesis of background pathology of the ectocervix, dysplasia and preinvasive cancer of the cervix uteri].
    Maksimov SIa; Savicheva AM; Bashmakova MA; Shaimardanova GI; Shipitsina EV; Rybina EV
    Vopr Onkol; 1999; 45(6):627-9. PubMed ID: 10703510
    [No Abstract]   [Full Text] [Related]  

  • 43. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil.
    Cavalcanti SM; Zardo LG; Passos MR; Oliveira LH
    J Infect; 2000 Jan; 40(1):80-7. PubMed ID: 10762117
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell proliferative responses against human papillomavirus type 16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection.
    de Gruijl TD; Bontkes HJ; Stukart MJ; Walboomers JM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2183-91. PubMed ID: 8811018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi.
    Motti PG; Dallabetta GA; Daniel RW; Canner JK; Chiphangwi JD; Liomba GN; Yang L; Shah KV
    J Infect Dis; 1996 Mar; 173(3):714-7. PubMed ID: 8627037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of type-specific human papillomavirus infection among cytologically normal women.
    Hsing AW; Schiffman M; Zhang T; Greer CE; Chen CJ; You SL; Hsieh CY; Huang TW; Liaw KL; Manos M
    J Infect Dis; 1994 Aug; 170(2):498. PubMed ID: 8035046
    [No Abstract]   [Full Text] [Related]  

  • 47. [Epidemiology and natural history of genital infection by human papillomavirus].
    Riethmuller D; Schaal JP; Mougin C
    Gynecol Obstet Fertil; 2002 Feb; 30(2):139-46. PubMed ID: 11910884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Localisation of HIV-1 to human papillomavirus associated cervical lesions.
    Vernon SD; Zaki SR; Reeves WC
    Lancet; 1994 Oct; 344(8927):954-5. PubMed ID: 7934364
    [No Abstract]   [Full Text] [Related]  

  • 49. Detecting every genital papilloma virus infection: what does it mean?
    Crum CP
    Am J Pathol; 1998 Dec; 153(6):1667-71. PubMed ID: 9846955
    [No Abstract]   [Full Text] [Related]  

  • 50. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.
    Levi JE; Fernandes S; Tateno AF; Motta E; Lima LP; Eluf-Neto J; Pannuti CS
    Gynecol Oncol; 2004 Jan; 92(1):225-31. PubMed ID: 14751163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.
    Xi LF; Touré P; Critchlow CW; Hawes SE; Dembele B; Sow PS; Kiviat NB
    Int J Cancer; 2003 Mar; 103(6):803-9. PubMed ID: 12516102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation between human papillomavirus type 16 and potential for progression of minor-grade cervical disease.
    Downey GP; Bavin PJ; Deery AR; Crow J; Griffiths PD; Emery VC; Walker PG
    Lancet; 1994 Aug; 344(8920):432-5. PubMed ID: 7914563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human papillomavirus testing in cervical cancer screening.
    Franceschi S; Mahé C
    Br J Cancer; 2005 May; 92(9):1591-2. PubMed ID: 15870829
    [No Abstract]   [Full Text] [Related]  

  • 55. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Physiopathology and epidemiology of HPV anogenital diseases].
    Riethmuller D
    Ann Dermatol Venereol; 2000; 127(10 Suppl):3S5-3S9. PubMed ID: 11116862
    [No Abstract]   [Full Text] [Related]  

  • 57. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1).
    Heard I; Tassie JM; Schmitz V; Mandelbrot L; Kazatchkine MD; Orth G
    Obstet Gynecol; 2000 Sep; 96(3):403-9. PubMed ID: 10960634
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study.
    Dalstein V; Riethmuller D; Prétet JL; Le Bail Carval K; Sautière JL; Carbillet JP; Kantelip B; Schaal JP; Mougin C
    Int J Cancer; 2003 Sep; 106(3):396-403. PubMed ID: 12845680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Schiller JT; Stukart MJ; Groot BS; Chabaud MM; Remmink AJ; Verheijen RH; Helmerhorst TJ; Meijer CJ; Scheper RJ
    J Natl Cancer Inst; 1997 May; 89(9):630-8. PubMed ID: 9150187
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of infection with carcinogenic human papillomavirus among older women.
    Sellors JW; Karwalajtys TL; Kaczorowski JA; Mahony JB; Lytwyn A; Chong S; Sparrow J; Lorincz A;
    CMAJ; 2002 Oct; 167(8):871-3. PubMed ID: 12406945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.